The FDA Adverse Event Reporting System (FAERS) was used to evaluate the associations between oral anticoagulants (OACs) and acute kidney injury (AKI). Disproportionality analysis were applied to data
Top 20 least sparse features. The top 20 least sparse multi-variate features per dataset and patient group (i.e., ADE positive and ADE negative patients). The feature names are encoded as Nomenclature
Secondary immunodeficiency is becoming a greater medical concern as the usage of immunosuppressive and biological treatments has increased. Individuals with certain medical conditions, such as hematol